Your browser doesn't support javascript.
loading
Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3 mL per injection site.
Ng, Pamela; Incekol, Diana; Lee, Roy; Paisley, Emma; Dara, Celina; Brandle, Ian; Kaufman, Marina; Chen, Christine; Trudel, Suzanne; Tiedemann, Rodger; Reece, Donna; Kukreti, Vishal.
Afiliação
  • Ng P; Dept. of Pharmacy, Princess Margaret Cancer Centre, UHN Toronto, ON Pamela.Ng@uhn.ca.
  • Incekol D; Dept. of Nursing, Princess Margaret Cancer Centre, UHN, Toronto, ON.
  • Lee R; Dept. of Pharmacy, Princess Margaret Cancer Centre, UHN Toronto, ON.
  • Paisley E; Dept. of Nursing, Princess Margaret Cancer Centre, UHN, Toronto, ON.
  • Dara C; Dept. of Pharmacy, Princess Margaret Cancer Centre, UHN Toronto, ON.
  • Brandle I; Dept. of Nursing, Princess Margaret Cancer Centre, UHN, Toronto, ON.
  • Kaufman M; Dept. of Nursing, Princess Margaret Cancer Centre, UHN, Toronto, ON.
  • Chen C; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, UHN, Toronto, ON.
  • Trudel S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, UHN, Toronto, ON.
  • Tiedemann R; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, UHN, Toronto, ON.
  • Reece D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, UHN, Toronto, ON.
  • Kukreti V; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, UHN, Toronto, ON.
J Oncol Pharm Pract ; 21(4): 285-92, 2015 Aug.
Article em En | MEDLINE | ID: mdl-24781451

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bortezomib / Antineoplásicos Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Oncol Pharm Pract Assunto da revista: FARMACIA Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bortezomib / Antineoplásicos Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Oncol Pharm Pract Assunto da revista: FARMACIA Ano de publicação: 2015 Tipo de documento: Article